Alzheimer's disease therapeutics (DuPont/Scios)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAlzheimer's disease therapeutics (DuPont/Scios)
Drug Alias NameRE-978IN-973RE-987SR-973
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein inhibitorsMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinaseBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Pharma Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScios IncBristol-Myers Squibb Pharma Company
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A